DIANNE OCAMPO: Open Payments
NPI 1316500853 · RED BANK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 21 payments from 8 companies in 2025. Trend: 2023 $19 · 2024 $31 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $242 |
| Alkermes, Inc. | 4 | $68 |
| Neurocrine BioSciences, Inc. | 3 | $58 |
| Vanda Pharmaceuticals Inc. | 3 | $51 |
| Janssen Pharmaceuticals, Inc | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| ABBVIE INC. | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: UZEDY, ARISTADA, INGREZZA, FANAPT, REXULTI, INVEGA SUSTENNA, SPRAVATO, AUSTEDO XR.
Industry payments across NJ — which companies pay providers there.
